Ibuprofen and Bronchitis chronic - a phase IV clinical study of FDA data

Summary:

Bronchitis chronic is found among people who take Ibuprofen, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ibuprofen and have Bronchitis chronic. It is created by eHealthMe based on reports of 204,574 people who have side effects when taking Ibuprofen from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 03, 2023

204,574 people reported to have side effects when taking Ibuprofen.
Among them, 68 people (0.03%) have Bronchitis chronic.

What is Ibuprofen?

Ibuprofen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 210,443 Ibuprofen users for its effectiveness, alternative drugs and more.

What is Bronchitis chronic?

Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic) is found to be associated with 1,003 drugs and 525 conditions by eHealthMe.

Number of Ibuprofen and Bronchitis chronic reports submitted per year:

Could Ibuprofen cause Bronchitis chronic?

Time on Ibuprofen when people have Bronchitis chronic *:

Gender of people who have Bronchitis chronic when taking Ibuprofen *:

female: 52.24 %
male: 47.76 %

Age of people who have Bronchitis chronic when taking Ibuprofen *:

Common drugs people take besides Ibuprofen *:

Common side effects people have besides Bronchitis chronic *:

Stress And Anxiety: 24 people, 35.29%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 24 people, 35.29%
Breathing Difficulty: 22 people, 32.35%
Dizziness: 18 people, 26.47%
Muscle Spasms (muscle contraction): 18 people, 26.47%
Joint Pain: 17 people, 25.00%
Spinal Osteoarthritis (joint cartilage loss in spine): 17 people, 25.00%
Weakness: 16 people, 23.53%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 16 people, 23.53%
Hyperhidrosis (abnormally increased sweating): 16 people, 23.53%

Common conditions people have *:

Multiple Myeloma (cancer of the plasma cells): 12 people, 17.65%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 7.35%
High Blood Pressure: 4 people, 5.88%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.88%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 5.88%
Neuralgia (pain in one or more nerves): 4 people, 5.88%
Asthma: 2 people, 2.94%
Bipolar Disorder (mood disorder): 2 people, 2.94%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 2.94%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Ibuprofen and have Bronchitis chronic?

Check whether Bronchitis chronic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

Related studies

How severe was Bronchitis chronic and when was it recovered:

Bronchitis chronic in Ibuprofen

Expand to all the drugs that have ingredients of ibuprofen:

Bronchitis chronic and drugs with ingredients of ibuprofen

Alternative drugs to, pros and cons of Ibuprofen:

Ibuprofen (210,443 reports)

Common Ibuprofen side effects:

Pain: 17,474 reports
Fatigue (feeling of tiredness): 15,323 reports
Drug ineffective: 14,992 reports
Headache (pain in head): 13,160 reports
Rashes (redness): 11,328 reports
Joint pain: 10,717 reports
Nausea and vomiting: 10,601 reports
Breathing difficulty: 10,285 reports

Browse all side effects of Ibuprofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Bronchitis chronic treatments and more:

Bronchitis chronic (7,911 reports)

COVID vaccines that are related to Bronchitis chronic:

Common drugs associated with Bronchitis chronic:

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibuprofen) and Ibuprofen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.